Literature DB >> 26129789

Assessing the relative efficacy of new drugs: an emerging opportunity.

Hans-Georg Eichler1, Andrew Thomson1, Irmgard Eichler1, Sebastian Schneeweiss2.   

Abstract

The increasing availability of individual-level data from clinical trials could allow the relative efficacy of new drugs to be assessed in a robust, cost-effective and timely way.

Mesh：

Substances：

Year:  2015        PMID： 26129789     DOI： 10.1038/nrd4664

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


  4 in total

1.  Data sharing, year 1--access to data from industry-sponsored clinical trials.

Authors:  Brian L Strom; Marc Buyse; John Hughes; Bartha M Knoppers
Journal:  N Engl J Med       Date:  2014-10-15       Impact factor: 91.245

2.  Group seeks standardization for what clinical trials must measure.

Authors:  Amanda B Keener
Journal:  Nat Med       Date:  2014-08       Impact factor: 53.440

3.  Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.

Authors:  Sebastian Schneeweiss; Joshua J Gagne; Amanda R Patrick; Niteesh K Choudhry; Jerry Avorn
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-07-10

4.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Authors:  C Bombardier; L Laine; A Reicin; D Shapiro; R Burgos-Vargas; B Davis; R Day; M B Ferraz; C J Hawkey; M C Hochberg; T K Kvien; T J Schnitzer
Journal:  N Engl J Med       Date:  2000-11-23       Impact factor: 91.245
  4 in total
  5 in total

1.  HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?

Authors:  Livio Garattini; Anna Padula
Journal:  Eur J Health Econ       Date:  2020-02

Review 2.  The value of anticancer drugs - a regulatory view.

Authors:  Francesco Pignatti; Ulla Wilking; Douwe Postmus; Nils Wilking; Julio Delgado; Jonas Bergh
Journal:  Nat Rev Clin Oncol       Date:  2021-12-06       Impact factor: 66.675

Review 3.  Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical study.

Authors:  Adriani Nikolakopoulou; Dimitris Mavridis; Toshi A Furukawa; Andrea Cipriani; Andrea C Tricco; Sharon E Straus; George C M Siontis; Matthias Egger; Georgia Salanti
Journal:  BMJ       Date:  2018-02-28

Review 4.  Glycans as Targets for Drug Delivery in Cancer.

Authors:  Francisca Diniz; Pedro Coelho; Henrique O Duarte; Bruno Sarmento; Celso A Reis; Joana Gomes
Journal:  Cancers (Basel)       Date:  2022-02-12       Impact factor: 6.639

5.  Planning a future randomized clinical trial based on a network of relevant past trials.

Authors:  Georgia Salanti; Adriani Nikolakopoulou; Alex J Sutton; Stephan Reichenbach; Sven Trelle; Huseyin Naci; Matthias Egger
Journal:  Trials       Date:  2018-07-11       Impact factor: 2.279
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.